Freestone Capital Holdings Has Upped Its Sanofi (SNY) Stake by $4.29 Million; Somerset Capital Management Llp Decreased Its Yandex Nv (YNDX) Position by $314,589

April 17, 2018 - By Maria Brooks

Yandex N.V. (NASDAQ:YNDX) Logo

Somerset Capital Management Llp decreased its stake in Yandex Nv (YNDX) by 0.28% based on its latest 2017Q4 regulatory filing with the SEC. Somerset Capital Management Llp sold 9,533 shares as the company’s stock rose 25.49% while stock markets declined. The institutional investor held 3.41 million shares of the programming company at the end of 2017Q4, valued at $112.63M, down from 3.42M at the end of the previous reported quarter. Somerset Capital Management Llp who had been investing in Yandex Nv for a number of months, seems to be less bullish one the $11.00B market cap company. The stock increased 1.97% or $0.65 during the last trading session, reaching $33.63. About 25.89M shares traded or 626.23% up from the average. Yandex N.V. (NASDAQ:YNDX) has risen 79.21% since April 17, 2017 and is uptrending. It has outperformed by 67.66% the S&P500.

Freestone Capital Holdings Llc increased its stake in Sanofi (SNY) by 108.27% based on its latest 2017Q4 regulatory filing with the SEC. Freestone Capital Holdings Llc bought 102,217 shares as the company’s stock declined 8.41% with the market. The institutional investor held 196,629 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $8.46 million, up from 94,412 at the end of the previous reported quarter. Freestone Capital Holdings Llc who had been investing in Sanofi for a number of months, seems to be bullish on the $101.61 billion market cap company. The stock increased 0.47% or $0.19 during the last trading session, reaching $40.75. About 778,103 shares traded. Sanofi (NYSE:SNY) has declined 13.31% since April 17, 2017 and is downtrending. It has underperformed by 24.86% the S&P500.

Among 12 analysts covering Sanofi-aventis Sa (NYSE:SNY), 1 have Buy rating, 2 Sell and 9 Hold. Therefore 8% are positive. Sanofi-aventis Sa had 25 analyst reports since October 15, 2015 according to SRatingsIntel. On Wednesday, November 15 the stock rating was upgraded by Barclays Capital to “Equal-Weight”. The rating was maintained by JP Morgan with “Neutral” on Friday, April 21. The stock of Sanofi (NYSE:SNY) has “Hold” rating given on Tuesday, May 3 by HSBC. The firm has “Neutral” rating by Goldman Sachs given on Monday, November 7. As per Thursday, April 6, the company rating was initiated by Argus Research. The firm has “Buy” rating by Berenberg given on Thursday, September 8. The stock has “Reduce” rating by HSBC on Friday, April 7. The stock of Sanofi (NYSE:SNY) earned “Neutral” rating by BNP Paribas on Tuesday, September 13. The stock of Sanofi (NYSE:SNY) has “Underweight” rating given on Friday, December 1 by Morgan Stanley. Barclays Capital downgraded Sanofi (NYSE:SNY) on Tuesday, January 23 to “Underweight” rating.

Freestone Capital Holdings Llc, which manages about $1.44B US Long portfolio, decreased its stake in Buckeye Partners LP (NYSE:BPL) by 27,529 shares to 61,229 shares, valued at $3.03 million in 2017Q4, according to the filing. It also reduced its holding in Microsoft Corp (NASDAQ:MSFT) by 6,522 shares in the quarter, leaving it with 103,525 shares, and cut its stake in Pitney Bowes Inc (NYSE:PBI).

Among 9 analysts covering Yandex N.V. (NASDAQ:YNDX), 7 have Buy rating, 0 Sell and 2 Hold. Therefore 78% are positive. Yandex N.V. had 22 analyst reports since July 31, 2015 according to SRatingsIntel. As per Friday, May 6, the company rating was downgraded by Citigroup. On Monday, July 18 the stock rating was initiated by HSBC with “Buy”. The firm has “Buy” rating by Raiffeisen given on Monday, October 12. The stock of Yandex N.V. (NASDAQ:YNDX) earned “Outperform” rating by Credit Suisse on Friday, December 30. As per Wednesday, October 25, the company rating was maintained by Deutsche Bank. On Tuesday, November 17 the stock rating was upgraded by Morgan Stanley to “Overweight”. Deutsche Bank maintained the stock with “Buy” rating in Tuesday, October 6 report. The firm has “Neutral” rating by Goldman Sachs given on Wednesday, September 16. The company was downgraded on Tuesday, August 4 by Zacks. Deutsche Bank maintained the stock with “Buy” rating in Friday, July 14 report.

Sanofi (NYSE:SNY) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Maria Brooks

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: